Filter
4473
Filtered Results: 4473
Text search:
World
Health
Organization
Africa
Region
Featured
Recommendations
321
New Publications
1143
Language
Document type
No document type
2502
Studies & Reports
1038
Guidelines
382
Manuals
181
Strategic & Response Plan
176
Fact sheets
66
Training Material
50
Situation Updates
45
Resource Platforms
18
Infographics
12
Online Courses
2
Brochures
1
Countries / Regions
Global
235
Kenya
149
Ethiopia
137
Sierra Leone
131
Africa
128
Liberia
114
Uganda
107
Nigeria
92
Latin America and the Carribbean
92
Tanzania
88
South Africa
82
Ghana
81
Malawi
79
Rwanda
64
Zambia
63
Congo, Democratic Republic of
61
India
59
Western and Central Europe
52
Namibia
49
Guinea
48
Mozambique
47
West and Central Africa
44
Syria
43
South Sudan
41
East and Southern Africa
41
Senegal
40
Nepal
40
Lesotho
40
Middle East and North Africa
40
Zimbabwe
35
Burkina Faso
31
South–East Asia Region
30
Asia
30
Cameroon
28
Bangladesh
25
Colombia
24
Botswana
24
Venezuela
24
Myanmar / Burma
23
Central African Republic
20
Ukraine
20
Benin
19
Brazil
19
Yemen
19
Eastern Europe
19
Sudan
18
Eswatini/ Swaziland
18
Somalia
16
Madagascar
16
Russia
16
Pakistan
15
Indonesia
15
Mali
14
Philippines
14
Afghanistan
14
Haiti
13
Cambodia
12
Eastern Europe and Central Asia
12
Thailand
11
Paraguay
10
Côte d’Ivoire / Ivory Coast
9
Germany
9
China
9
Ecuador
9
Chile
8
Western Pacific Region
8
Peru
7
Angola
7
Guinea-Bissau
6
Iraq
6
Lebanon
6
Chad
6
Papua New Guinea
6
Burundi
6
Mexico
6
North America
6
Niger
5
Togo
5
Jordan
5
Gambia
5
Argentina
5
Libya
5
Vietnam
5
Bolivia
4
Southern Africa
4
Iran
4
Georgia
4
Morocco
3
North Macedonia
3
Sri Lanka
3
Palestine
3
Djibouti
3
Moldova
3
Jamaica
3
Japan
3
Mauritius
3
USA
2
Saudi Arabia
2
Egypt
2
Malaysia
2
Mauritania
2
Serbia
2
El Salvador
2
Greece
2
Italy
2
Albania
2
Armenia
2
Qatar
2
Kyrgyzstan
2
Gabon
2
Tunisia
2
Portugal
2
Spain
2
Bosnia and Herzegovina
2
Turkey
1
Vanuatu
1
Dominican Republic
1
Hungary
1
Cuba
1
Honduras
1
Guatemala
1
Cape Verde
1
Nicaragua
1
Solomon Islands
1
Poland
1
North Korea
1
Laos
1
Congo-Brazzaville
1
Canada
1
Timor Leste/ East Timor
1
Tajikistan
1
Bulgaria
1
Romania
1
Kazakhstan
1
Turkmenistan
1
Belgium
1
United Kingdom
1
Norway
1
Belarus
1
Israel
1
Authors & Publishers
Publication Years
Category
Countries
1556
Clinical Guidelines
356
Public Health
286
Women & Child Health
240
Key Resources
194
Capacity Building
68
Pharmacy & Technologies
45
Annual Report MEDBOX
2
Toolboxes
HIV
381
COVID-19
331
Mental Health
284
TB
235
Planetary Health
233
Ebola
197
Rapid Response
170
Disability
159
NTDs
150
AMR
125
Global Health Education
112
Conflict
106
NCDs
93
Refugee
91
Caregiver
82
Pharmacy
61
Health Financing Toolbox
55
Natural Hazards
51
Zika
40
Polio
34
Cholera
27
Social Ethics
14
Specific Hazards
11
South Sudan
2
Typhoon
1
This document sets out, therefore, to explain the socioeconomic value of investing in the fight against NTDs and highlights priorities for global investment attention. Our work was guided by the need not only for
additional funding and funders but also for the need to understand the current funding...
These guidelines provide updated evidence-based recommendations on the priority HCV-related topics from the 2018 WHO Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C infection and the 2017 WHO Guidelines on hepatitis B and C testing. These priority areas are:
...
Cities are uniquely positioned to understand local needs and respond rapidly to changing conditions to safeguard health. These changes require strong city leadership to implement multisectoral, health-relevant policies and public services that engage communities. The response to malaria must be an i...
31 Oct 2022 his plan outlines how the ACT-Accelerator will support countries as the world transitions to long-term COVID-19 control.
Recognizing the evolving nature of the COVID-19 virus and pandemic, the plan outlines changes to ACT-A’s set-up and ways of working, to ensure countries co...
Policy Brief. More languages available here https://apps.who.int/iris/handle/10665/179517
The document explains why vector control is important in national programmes and describes the preparation of a tailor-made vector control plan for national programmes. It outlines entomological procedures for regular and specific vector control and how data should be analysed for better overall und...
Meeting of the Neglected Tropical Diseases Strategic and Technical Advisory
Group’s Monitoring and Evaluation Subgroup on Disease-specific Indicators
The WHO Global Antimicrobial Resistance and Use Surveillance System (GLASS) was launched in 2015 to foster AMR surveillance and inform strategies to contain AMR. The system started with surveillance of AMR in bacteria causing common human infections and has expanded its scope to include surveillance...
Recency assays use one or more biomarkers to identify whether HIV infection in a person is recent (usually within a year or less) or longstanding. Recency assays have been used to estimate incidence in representative cross-sectional surveys and in epidemiological studies to better understand the pat...
Trachoma is the leading infectious cause of blindness (2). It is characterized by repeated
conjunctival infection with particular strains of Chlamydia trachomatis. This scars the conjunctivae and,
in some cases, leads to trichiasis with or without entropion. The abrasive action of eyelashes can
d...
The Strategic Advisory Group of Experts (SAGE) on Immunization held a meeting on 3-6 October 2022. This report summarizes the discussions, conclusions and recommendations.
It covers the following items:
Global Reports
Immunization Agenda 2030 and Regional reports
Monkeypox
RSV
COVID-19 vacci...
The Practical manual on laboratory strengthening, 2022 update provides practical guidance on implementation of WHO recommendations and best practices for TB laboratory strengthening. It is an updated version of the GLI Practical Guide to Laboratory Strengthening published in 2017 and provides the la...
Localized cutaneous leishmaniasis and its evolving forms (diffuse cutaneous leishmaniasis, mucosal leishmaniasis and cutaneous leishmaniasis recidivans), together with the sequela of visceral leishmaniasis (post-kala-azar dermal leishmaniasis), account for about one million cases of dermal leishmani...
As of 12 December 2022, over 645 million people worldwide have been diagnosed with COVID-19, with over 6.6 million deaths (4).
The Omicron variant, which emerged in late November 2021, and its subvariants, are now the dominant circulating viruses, contributing to the ongoing surge in several countr...
The WHO continuously reviews available data on SARS-CoV-2 variants of concern. For this version, the global epidemiological
situation of the COVID-19 pandemic as of 21 January 2022 – at a time when the Omicron VOC had been identified in 171
countries across all six WHO Regions and was rapidly re...
The WHO Pharmaceuticals Newsletter provides you with the latest information on the safety of medicinal products and regulatory actions taken by authorities around the world.
In addition, this edition includes summary and recommendations from the virtual meeting of the members of the WHO Programme f...
Rabies has an enormous impact on both agriculture and conservation biology, but its greatest burden is undeniably on public health. As such, routine methods for rapid risk assessment after human exposures to rabies as well as applications for laboratory-based surveillance, production of biologicals ...
En la actualidad, los daños que sufren los pacientes a causa de una atención poco segura constituyen un desafío
importante y creciente para la salud pública mundial y son una de las principales causas de muerte y discapacidad
en todo el mundo. La mayor parte de estos daños son evitables. Ahor...
Access to NCD medicines: emergent issues during the COVID-19 pandemic and key structural factors
recommended
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys...
This document aims to assist countries to take the first step towards better considering gender and equity issues in their efforts to tackle antimicrobial resistance (AMR), to inform the implementation of strategies in national action plans and contribute to improved reach and effectiveness of AMR e...
